GP-Act III Acquisition (GPAT) Competitors $10.53 -0.02 (-0.18%) As of 10:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock GPAT vs. ONCHU, ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, and ANSCUShould you be buying GP-Act III Acquisition stock or one of its competitors? The main competitors of GP-Act III Acquisition include 1RT Acquisition (ONCHU), A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), and Agriculture & Natural Solutions Acquisition (ANSCU). These companies are all part of the "trading" industry. GP-Act III Acquisition vs. Its Competitors 1RT Acquisition A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition GP-Act III Acquisition (NASDAQ:GPAT) and 1RT Acquisition (NASDAQ:ONCHU) are both investment offices industry companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment. Does the media refer more to GPAT or ONCHU? In the previous week, 1RT Acquisition had 2 more articles in the media than GP-Act III Acquisition. MarketBeat recorded 2 mentions for 1RT Acquisition and 0 mentions for GP-Act III Acquisition. GP-Act III Acquisition's average media sentiment score of 0.00 beat 1RT Acquisition's score of -0.50 indicating that GP-Act III Acquisition is being referred to more favorably in the media. Company Overall Sentiment GP-Act III Acquisition Neutral 1RT Acquisition Negative Is GPAT or ONCHU more profitable? Company Net Margins Return on Equity Return on Assets GP-Act III AcquisitionN/A N/A N/A 1RT Acquisition N/A N/A N/A Which has preferable valuation and earnings, GPAT or ONCHU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGP-Act III AcquisitionN/AN/AN/AN/AN/A1RT AcquisitionN/AN/AN/AN/AN/A SummaryGP-Act III Acquisition and 1RT Acquisition tied by winning 1 of the 2 factors compared between the two stocks. Get GP-Act III Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for GPAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GPAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GPAT vs. The Competition Export to ExcelMetricGP-Act III AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$178.97M$12.16B$9.65BDividend YieldN/AN/A5.64%4.14%P/E RatioN/AN/A19.9325.06Price / SalesN/AN/A26.1677.08Price / CashN/A36,784.7921.4958.58Price / BookN/AN/A2.115.67Net IncomeN/A-$160K$1.00B$265.39M7 Day Performance-0.27%-0.41%1.27%2.54%1 Month Performance-0.09%-0.13%0.19%1.89%1 Year Performance5.10%4.95%543.43%24.09% GP-Act III Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GPATGP-Act III AcquisitionN/A$10.53-0.2%N/A+5.3%$0.00N/A0.00N/AONCHU1RT AcquisitionN/A$10.52-0.7%N/AN/A$0.00N/A0.002Negative NewsQuiet Period ExpirationASPCUA SPAC III AcquisitionN/A$10.50+1.3%N/AN/A$0.00N/A0.00N/APositive NewsGap UpAGBAWAGBA GroupN/A$0.06-0.5%N/A-71.5%$0.00$38.55M0.00152AGNCPAGNC InvestmentN/A$25.32-0.5%N/A+5.7%$0.00$496M0.0050News CoverageNegative NewsShort Interest ↑AGNCOAGNC InvestmentN/A$25.52-0.2%N/A+3.2%$0.00$496M0.0050AGNCNAGNC InvestmentN/A$25.78-0.5%N/A+0.0%$0.00$496M0.0050AGNCMAGNC InvestmentN/A$25.13+0.2%N/A+0.3%$0.00$496M0.0050AGNCLAGNC InvestmentN/A$25.32-0.4%N/A+5.4%$0.00$496M0.0050Positive NewsANSCWAgriculture & Natural Solutions AcquisitionN/A$0.25+8.6%N/A+47.0%$0.00N/A0.00N/AANSCUAgriculture & Natural Solutions AcquisitionN/A$10.54-11.4%N/AN/A$0.00N/A0.00N/AGap Up Related Companies and Tools Related Companies 1RT Acquisition Competitors A SPAC III Acquisition Competitors AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors Agriculture & Natural Solutions Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GPAT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GP-Act III Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GP-Act III Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GPAT Stock Alerts